Replies to post #121371 on Cytodyn Inc (CYDY)

[hopester]

Leronlimab Data- Unimpressive $3.43/sh
Approval- Probably not. 6 months to 1 year to find out. Waste of time and money.
Uplist- Well! Where is it? Not happening! Nasdaq has reviewed already . Shareholders are not being told.